(Q48700410)

14 February 2018

title

Development of an optimal lidocaine infusion strategy for neonatal seizures (English)

1 reference

14 February 2018

0 references

Mirte M Malingré

1

1 reference

14 February 2018

Linda G M Van Rooij

2

1 reference

14 February 2018

Carin M A Rademaker

3

1 reference

14 February 2018

Mona C Toet

4

1 reference

14 February 2018

Tessa F F T Ververs

5

1 reference

14 February 2018

Charlotte van Kesteren

6

1 reference

14 February 2018

Linda S de Vries

7

1 reference

14 February 2018

publication date

12 May 2006

1 reference

14 February 2018

European Journal of Pediatrics

published in

1 reference

14 February 2018

volume

165

1 reference

14 February 2018

issue

9

1 reference

14 February 2018

page(s)

598-604

1 reference

14 February 2018

Effect of Lidocaine on Ventricular Arrhythmias in Patients with Coronary Heart Disease

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00431-006-0136-X

Lidocaine in the prevention of primary ventricular fibrillation. A double-blind, randomized study of 212 consecutive patients.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00431-006-0136-X

Cardiac arrhythmias in neonates receiving lidocaine as anticonvulsive treatment.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00431-006-0136-X

Therapeutic drug monitoring: antiarrhythmic drugs

21 January 2018

1 reference

12 December 2020

The convulsant potency of lidocaine and its N-dealkylated metabolites

1 reference

12 December 2020

Clinical Pharmacokinetics of Lignocaine

1 reference

12 December 2020

Anti-arrhythmic effects of lidocaine metabolites

1 reference

12 December 2020

Lidocaine for treatment of severe seizures in newborn infants. II. Blood concentrations of lidocaine and metabolites during intravenous infusion.

1 reference

12 December 2020

Neonatal mydriasis: intravenous lidocaine adverse reaction

1 reference

12 December 2020

Adult respiratory distress syndrome following administration of lidocaine.

1 reference

12 December 2020

Cytochrome P450 1A2 is a major determinant of lidocaine metabolism in vivo: effects of liver function

1 reference

12 December 2020

Lidocaine and seizures

1 reference

12 December 2020

Xpose--an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM

1 reference

12 December 2020

Recurrent seizures in a neonate after lidocaine administration

1 reference

12 December 2020

Intravenous lidocaine in the treatment of convulsions in the neonatal period: monitoring plasma levels.

1 reference

12 December 2020

Prolonged seizures associated with the use of viscous lidocaine

1 reference

12 December 2020

Population pharmacokinetic modeling: the importance of informative graphics

1 reference

12 December 2020

Statistical graphics in pharmacokinetics and pharmacodynamics: a tutorial

1 reference

12 December 2020

Lidocaine for treatment of severe seizures in newborn infants. I. Clinical effects and cerebral electrical activity monitoring

1 reference

12 December 2020

10.1007/S00431-006-0136-X

Identifiers

DOI

1 reference

14 February 2018

1 reference

14 February 2018